Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 120

Sort by

Sort Order Select

Journal Articles

Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders

Blood Adv (2021) 5 (16): 3188–3198.

https://doi.org/10.1182/bloodadvances.2020004056

Published: 2021

Includes: Supplemental data

Journal Articles

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

Andrew Jay Portuguese, Cassandra Sunga, Rebecca Kruse-Jarres, Terry Gernsheimer, Janis Abkowitz

Blood Adv (2021) 5 (13): 2794–2798.

https://doi.org/10.1182/bloodadvances.2021004957

Published: 2021

Journal Articles

Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma

Constantine S. Tam, Stephen Opat, David Simpson, Gavin Cull, Javier Munoz, Tycel J. Phillips, Won Seog Kim, Simon Rule, Siminder Kaur Atwal, Rachel Wei, William Novotny, Jane Huang, Michael Wang, Judith Trotman

Blood Adv (2021) 5 (12): 2577–2585.

https://doi.org/10.1182/bloodadvances.2020004074

Published: 2021

Includes: Supplemental data

Journal Articles

Low-cost transcriptional diagnostic to accurately categorize lymphomas in low- and middle-income countries

Fabiola Valvert, Oscar Silva, Elizabeth Solórzano-Ortiz, Maneka Puligandla, Marcos Mauricio Siliézar Tala, Timothy Guyon, Samuel L. Dixon, Nelly López, Francisco López, César Camilo Carías Alvarado, Robert Terbrueggen, Kristen E. Stevenson, Yasodha Natkunam, David M. Weinstock, Edward L. Briercheck

Blood Adv (2021) 5 (10): 2447–2455.

https://doi.org/10.1182/bloodadvances.2021004347

Published: 2021

Includes: Supplemental data

Journal Articles

G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death

Eva De Smedt, Julie Devin, Catharina Muylaert, Nicolas Robert, Guilhem Requirand, Philip Vlummens, Laure Vincent, Guillaume Cartron, Ken Maes, Jerome Moreaux, Elke De Bruyne

Blood Adv (2021) 5 (9): 2325–2338.

https://doi.org/10.1182/bloodadvances.2020003217

Published: 2021

Includes: Supplemental data

Journal Articles

LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C/EBPα

Kensaku Kohrogi, Shinjiro Hino, Akihisa Sakamoto, Kotaro Anan, Ryuta Takase, Hirotaka Araki, Yuko Hino, Kazutaka Araki, Tetsuya Sato, Kimitoshi Nakamura, Mitsuyoshi Nakao

Blood Adv (2021) 5 (9): 2305–2318.

https://doi.org/10.1182/bloodadvances.2020003521

Published: 2021

Includes: Supplemental data

Journal Articles

Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma

Donald L. Patrick, Annette Powers, Monika Parisi Jun, Yeonhee Kim, Jacob Garcia, Christine Dehner, David G. Maloney

Blood Adv (2021) 5 (8): 2245–2255.

https://doi.org/10.1182/bloodadvances.2020003503

Published: 2021

Includes: Supplemental data

Journal Articles

Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies

Anand A. Patel, Kirk Cahill, Caner Saygin, Olatoyosi Odenike

Blood Adv (2021) 5 (8): 2264–2271.

https://doi.org/10.1182/bloodadvances.2020002929

Published: 2021

Journal Articles

Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma

Hilma J. van der Horst, Anne T. Gelderloos, Martine E. D. Chamuleau, Esther C. W. Breij, Sonja Zweegman, Inger S. Nijhof, Marije B. Overdijk, Tuna Mutis

Blood Adv (2021) 5 (8): 2165–2172.

https://doi.org/10.1182/bloodadvances.2020003731

Published: 2021

Includes: Supplemental data

Journal Articles

Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis

Christine S. Higham, Griffin Collins, Kristin A. Shimano, Alexis Melton, Sandhya Kharbanda, Lena E. Winestone, James N. Huang, Jasmeen Dara, Janel R. Long-Boyle, Christopher C. Dvorak

Blood Adv (2021) 5 (8): 2106–2114.

https://doi.org/10.1182/bloodadvances.2020003988

Published: 2021

Includes: Supplemental data

Journal Articles

Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years

Isabelle A. van Zeventer, Jonas B. Salzbrunn, Aniek O. de Graaf, Bert A. van der Reijden, H. Marike Boezen, Judith M. Vonk, Pim van der Harst, Jan Jacob Schuringa, Joop H. Jansen, Gerwin Huls

Blood Adv (2021) 5 (8): 2115–2122.

https://doi.org/10.1182/bloodadvances.2020004062

Published: 2021

Includes: Supplemental data

Journal Articles

Extended thromboprophylaxis for medically ill patients with cancer: a systemic review and meta-analysis

Soravis Osataphan, Rushad Patell, Thita Chiasakul, Alok A. Khorana, Jeffrey I. Zwicker

Blood Adv (2021) 5 (8): 2055–2062.

https://doi.org/10.1182/bloodadvances.2020004118

Published: 2021

Includes: Supplemental data

Journal Articles

The potential of proliferative and apoptotic parameters in clinical flow cytometry of myeloid malignancies

Stefan G. C. Mestrum, Anton H. N. Hopman, Frans C. S. Ramaekers, Math P. G. Leers

Blood Adv (2021) 5 (7): 2040–2052.

https://doi.org/10.1182/bloodadvances.2020004094

Published: 2021

Journal Articles

Lyman GH, Carrier M, Ay C, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021;5(4):927-974.

Blood Adv (2021) 5 (7): 1953.

https://doi.org/10.1182/bloodadvances.2021004734

Published: 2021

Journal Articles

Selective drug combination vulnerabilities in STAT3- and TP53-mutant malignant NK cells

Elina Parri, Heikki Kuusanmäki, Daria Bulanova, Satu Mustjoki, Krister Wennerberg

Blood Adv (2021) 5 (7): 1862–1875.

https://doi.org/10.1182/bloodadvances.2020003300

Published: 2021

Includes: Supplemental data

Journal Articles

Immunotherapy perspectives in the new era of B-cell editing

Natsuko Ueda, Marine Cahen, Yannic Danger, Jérôme Moreaux, Christophe Sirac, Michel Cogné

Blood Adv (2021) 5 (6): 1770–1779.

https://doi.org/10.1182/bloodadvances.2020003792

Published: 2021

Journal Articles

Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP

Alexandra Schifferli, Andrea Heiri, Paul Imbach, Susanne Holzhauer, Markus G. Seidel, Diane Nugent, Marc Michel, Thomas Kühne

Blood Adv (2021) 5 (6): 1617–1626.

https://doi.org/10.1182/bloodadvances.2020003004

Published: 2021

Journal Articles

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines

Alden A. Moccia, Kimberly Schaff, Ciara Freeman, Paul J. Hoskins, Richard J. Klasa, Kerry J. Savage, Tamara N. Shenkier, Randy D. Gascoyne, Joseph M. Connors, Laurie H. Sehn

Blood Adv (2021) 5 (5): 1483–1489.

https://doi.org/10.1182/bloodadvances.2020002982

Published: 2021

Includes: Supplemental data

Journal Articles

Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia

Christopher J. Walker, Krzysztof Mrózek, Hatice Gulcin Ozer, Deedra Nicolet, Jessica Kohlschmidt, Dimitrios Papaioannou, Luke K. Genutis, Marius Bill, Bayard L. Powell, Geoffrey L. Uy, Jonathan E. Kolitz, Andrew J. Carroll, Richard M. Stone, Ramiro Garzon, John C. Byrd, Ann-Kathrin Eisfeld, Albert de la Chapelle, Clara D. Bloomfield

Blood Adv (2021) 5 (5): 1474–1482.

https://doi.org/10.1182/bloodadvances.2020003727

Published: 2021

Includes: Supplemental data

Journal Articles

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

Margaret L. MacMillan, Keli L. Hippen, David H. McKenna, Diane Kadidlo, Darin Sumstad, Todd E. DeFor, Claudio G. Brunstein, Shernan G. Holtan, Jeffrey S. Miller, Erica D. Warlick, Daniel J. Weisdorf, John E. Wagner, Bruce R. Blazar

Blood Adv (2021) 5 (5): 1425–1436.

https://doi.org/10.1182/bloodadvances.2020003219

Published: 2021

Includes: Supplemental data

NARROW

Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma

Low-cost transcriptional diagnostic to accurately categorize lymphomas in low- and middle-income countries

G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death

LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C/EBPα

Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma

Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies

Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma

Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis

Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years

Extended thromboprophylaxis for medically ill patients with cancer: a systemic review and meta-analysis

The potential of proliferative and apoptotic parameters in clinical flow cytometry of myeloid malignancies

Lyman GH, Carrier M, Ay C, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021;5(4):927-974.

Selective drug combination vulnerabilities in STAT3- and TP53-mutant malignant NK cells

Immunotherapy perspectives in the new era of B-cell editing

Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines

Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only